|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||23.77 - 24.67|
|52-week range||13.89 - 44.34|
|Beta (5Y monthly)||0.98|
|PE ratio (TTM)||2.73|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
SAN DIEGO, December 06, 2023--Tandem Diabetes Care today announced the launch of updated t:slim X2™ insulin pump software with Dexcom G7 CGM integration in the United States.
SAN DIEGO, November 06, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:
SAN DIEGO, November 01, 2023--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Mark Novara as Executive Vice President and Chief Commercial Officer, effective November 13, 2023. Mr. Novara comes to Tandem with extensive global healthcare experience, having served in the diabetes, medical technology, and life sciences industries for nearly 25 years.